Your browser doesn't support javascript.
loading
Prediction of clinical pharmacokinetics of AMG 181, a human anti-α 4 ß 7 monoclonal antibody for treating inflammatory bowel diseases.
Li, Hong; Köck, Kathleen; Wisler, John A; Rees, William A; Prince, Peter J; Reynhardt, Kai O; Hsu, Hailing; Yu, Zhigang; Borie, Dominic C; Salinger, David H; Pan, Wei-Jian.
Afiliación
  • Li H; Pharmacokinetics and Drug Metabolism, Amgen Inc. Seattle, Washington.
  • Köck K; Pharmacokinetics and Drug Metabolism, Amgen Inc. Seattle, Washington.
  • Wisler JA; Comparative Biology and Safety Sciences, Amgen Inc. Thousand Oaks, California.
  • Rees WA; Medical Sciences, Amgen Inc. Seattle, Washington.
  • Prince PJ; Pharmacokinetics and Drug Metabolism, Amgen Inc. Seattle, Washington.
  • Reynhardt KO; Medical Sciences, Amgen Inc. Seattle, Washington.
  • Hsu H; Inflammation Discovery Research, Amgen Inc. Thousand Oaks, California.
  • Yu Z; Medical Sciences, Amgen Inc. Thousand Oaks, California.
  • Borie DC; Global Development, Amgen Inc. South San Francisco, California.
  • Salinger DH; Pharmacokinetics and Drug Metabolism, Amgen Inc. Seattle, Washington.
  • Pan WJ; Pharmacokinetics and Drug Metabolism, Amgen Inc. Seattle, Washington.
Pharmacol Res Perspect ; 3(1): e00098, 2015 Feb.
Article en En | MEDLINE | ID: mdl-25692016

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmacol Res Perspect Año: 2015 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmacol Res Perspect Año: 2015 Tipo del documento: Article